Regional banking stocks like Coastal Financial and GBank Financial dropped sharply due to poor Q2 earnings and a legal investigation. Teladoc Health's shares fell despite beating earnings estimates, as it lowered its 2026 outlook. Inverse leveraged ETFs tied to semiconductor stocks also suffered big losses, reflecting strong rallies in those tech stocks. These declines highlight sector-specific challenges and shifting investor sentiment amid mixed earnings and regulatory concerns.
Teladoc Health reported Q2 2026 revenue of $606.9 million, down 4% year-over-year, with a net loss of $38.9 million. The Integrated Care segment grew slightly by 1%, while the BetterHelp segment revenue dropped 12% due to a shift from cash-pay to ins...
Teladoc Health, a leader in virtual healthcare services, has seen its average analyst price target rise from $8.35 to $11.00, reflecting increased confidence in its market position. The stock recently jumped 6.1% with high trading volume, driven by r...
